Trial
NCT02333851
Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)
Phase IVTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Hospital Universitario Central de Asturias
Collaborators
Sanofi
Condition
Type 2 Diabetes Mellitus
Intervention
Mixtard 30:70 Novonordisk® twice daily
Why stopped
Safety reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-01-07